STERIS vs Viatris
STERIS (STE), health care, and Viatris (VTRS), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
STERIS is worth $25B on the stock market and Viatris $23.4B: STERIS is valued at 7% more. STERIS's operating margin in its latest fiscal year was 18.6% and Viatris's -18.6%. Over the past year STERIS's share price has moved +1.91% and Viatris's +93.7%.
Key facts
- STERIS market value
- $25B
- Viatris market value
- $23.4B
- STERIS P/E
- 30.5
- STERIS revenue
- $5.9BFY to 2026-03-31
- Viatris revenue
- $14.3BFY to 2025-12-31
- Superinvestors holding both
- 1
Market values as of .
| Measure | STERIS | Viatris |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2026-03-31 | 2025-12-31 |
| Size | ||
| Market cap | $25Bhigher | $23.4Blower |
| Revenue | $5.9Blower | $14.3Bhigher |
| Earnings | $782.3Mhigher | -$3.5Blower |
| Employees | 17,937lower | 30,000higher |
| Total assets | $10.7Blower | $37.2Bhigher |
| Valuation | ||
| P/E | 30.5 | — |
| P/S | 4.2higher | 1.6lower |
| P/B | — | 1.7 |
| Dividend yield | — | 2.31% |
| Profitability | ||
| Operating margin | 18.6%higher | -18.6%lower |
| Balance sheet | ||
| Net assets | $7.2Blower | $14.7Bhigher |
| Total liabilities | $3.5Blower | $22.5Bhigher |
| Total debt | $1.9Blower | $14.4Bhigher |
| Cash on hand | $439.6Mlower | $1.3Bhigher |
| Price change | ||
| Today | -1.46%lower | -1.40%higher |
| 1 year | +1.91%lower | +93.7%higher |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (1)
- Joel Greenblatt0.1% / 0.2%
STERIS only (0)
None of the tracked investors.
Viatris only (8)
- Christopher Davis5.5%
- Anthony Bozza3.2%
- Larry Robbins3.1%
- Bill Miller (founder)2.8%
- Harry Burn2.5%
- David Einhorn1.1%
- Louis Bacon0.3%
- Josef Lakonishok0.3%
Percentages are each holding's share of that investor's reported portfolio (under "Both": STERIS / Viatris). Who owns STE · Who owns VTRS
More on STERIS
Further comparisons
STERIS against its closest peers
Viatris against its closest peers
Learn
Questions and answers
Which is bigger, STERIS or Viatris?
By market value, STERIS is the larger: $25B against $23.4B for Viatris. By revenue in its latest fiscal year, Viatris is the larger: $14.3B against $5.9B for STERIS.
Which has the higher operating margin?
STERIS: 18.6%, against -18.6% for Viatris. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which has more debt?
Viatris: $14.4B, against $1.9B for STERIS. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.
Which superinvestors own both STERIS and Viatris?
In their latest 13F filings, Joel Greenblatt holds both.
Cite this page
Funkfolio, “STERIS vs Viatris”, data as of 17 November 2026. https://funkfolio.com/compare/ste-vs-vtrs
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.